Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jun 5;2(3):158-69.
doi: 10.1111/j.2040-1124.2011.00106.x.

Genetics and pathophysiology of neonatal diabetes mellitus

Affiliations
Review

Genetics and pathophysiology of neonatal diabetes mellitus

Rochelle N Naylor et al. J Diabetes Investig. .

Abstract

Neonatal diabetes mellitus (NDM) is the term commonly used to describe diabetes with onset before 6 months-of-age. It occurs in approximately one out of every 100,000-300,000 live births. Although this term encompasses diabetes of any etiology, it is recognized that NDM diagnosed before 6 months-of-age is most often monogenic in nature. Clinically, NDM subgroups include transient (TNDM) and permanent NDM (PNDM), as well as syndromic cases of NDM. TNDM often develops within the first few weeks of life and remits by a few months of age. However, relapse occurs in 50% of cases, typically in adolescence or adulthood. TNDM is most frequently caused by abnormalities in the imprinted region of chromosome 6q24, leading to overexpression of paternally derived genes. Mutations in KCNJ11 and ABCC8, encoding the two subunits of the adenosine triphosphate-sensitive potassium channel on the β-cell membrane, can cause TNDM, but more often result in PNDM. NDM as a result of mutations in KCNJ11 and ABCC8 often responds to sulfonylureas, allowing transition from insulin therapy. Mutations in other genes important to β-cell function and regulation, and in the insulin gene itself, also cause NDM. In 40% of NDM cases, the genetic cause remains unknown. Correctly identifying monogenic NDM has important implications for appropriate treatment, expected disease course and associated conditions, and genetic testing for at-risk family members. Early recognition of monogenic NDM allows for the implementation of appropriate therapy, leading to improved outcomes and potential societal cost savings. (J Diabetes Invest, doi:10.1111/j.2040-1124.2011.00106.x, 2011).

Keywords: Mutation; Neonatal diabetes mellitus; β‐Cell.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Approach to genetic testing for neonatal diabetes. UPD, uniparental isodisomy. If it is unclear if diabetes is permanent or transient, testing for both KCNJ11, the most common cause of permanent neonatal diabetes, and 6q24 chromosome abnormalities, the most common cause of transient neonatal diabetes, should be pursued. §Immune dysregulation, polyendocrinopathy, enteropathy, X‐linked (IPEX) should be considered as a potential cause of syndromic neonatal diabetes in males when associated with immune dysregulation, enteropathy and autoimmune endocrinopathies. It additionally can cause antibody‐positive neonatal diabetes.

Similar articles

Cited by

References

    1. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 2009; 360: 1646–1654 - PubMed
    1. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large‐scale association analysis. Nat Genet 2010; 42: 579–589 - PMC - PubMed
    1. Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta‐cell diabetes. Nat Clin Pract Endocrinol Metab 2008; 4: 200–213 - PubMed
    1. Edghill EL, Hattersley AT. Genetic disorders of the pancreatic beta cell and diabetes (permanent neonatal diabetes and maturity‐onset diabetes of the young) In: Seino S, Bell GI (eds). Pancreatic Beta Cell in Health and Disease. Springer, Japan, 2008; 389–420
    1. Stoy J, Greeley SAW, Paz VP, et al. Diagnosis and treatment of neonatal diabetes: an United States experience. Pediatr Diabetes 2008; 9: 450–459 - PMC - PubMed

LinkOut - more resources